Volume 15, Number 8—August 2009
Dispatch
Invasive Group B Streptococcal Disease in the Elderly, Minnesota, USA, 2003–2007
Neelay J. Kothari
, Craig A. Morin, Anita Glennen, Delois Jackson, Jane Harper, Stephanie J. Schrag, and Ruth Lynfield
, Craig A. Morin, Anita Glennen, Delois Jackson, Jane Harper, Stephanie J. Schrag, and Ruth LynfieldTable 2
Susceptibility of invasive GBS disease to erythromycin and clindamycin, Minnesota, 2003–2007*
| Susceptibility | No. (%) case-patients |
p value† | ||||
|---|---|---|---|---|---|---|
| 2003 (N = 133) | 2004 (N = 127) | 2005 (N = 131) | 2006 (N = 143) | 2007 (N = 121) | ||
| Erythromycin susceptible | 95 (71.4) | 86 (67.7) | 87 (66.4) | 90 (62.9) | 71 (58.7) | 0.023 |
| Clindamycin susceptible | 114 (85.7) | 105 (82.7) | 108 (82.4) | 116 (81.1) | 92 (76.0) | 0.057 |
*GBS, group B streptococcal.
†χ2 test for trend.
